Medical Radioisotopes Market

Nuclear medicine uses radiation to provide diagnostic information about the functioning of a person's specific organs, or to treat them. Diagnostic procedures using radioisotopes are now routine. Radiotherapy can be used to treat some medical conditions, especially cancer, using radiation to weaken or destroy particular targeted cells. The attributes of naturally decaying atoms, known as radioisotopes, give rise to several applications across many aspects of modern day life (see also information paper on The Many Uses of Nuclear Technology).There is widespread awareness of the use of radiation and radioisotopes in medicine, particularly for diagnosis (identification) and therapy (treatment) of various medical conditions.
Medical Radioisotopes Market contains market size and forecasts of Medical Radioisotopes in Global, including the following market information:
Global Medical Radioisotopes Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Medical Radioisotopes market was valued at 668.3 million in 2021 and is projected to reach US$ 886.3 million by 2028, at a CAGR of 4.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Mo-99 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Medical Radioisotopes include NRG, NTP Radioisotopes, ANSTO, IRE, Nordion, Curium Pharma, Eckert & Ziegler Strahlen, Polatom and China National Nuclear Corporation and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Medical Radioisotopes companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Medical Radioisotopes Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Medical Radioisotopes Market Segment Percentages, by Type, 2021 (%)
Mo-99
Co-60
Lutetium 177
Global Medical Radioisotopes Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Medical Radioisotopes Market Segment Percentages, by Application, 2021 (%)
Nuclear Therapy
Equipment Radioactive Source
Diagnosis
Global Medical Radioisotopes Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Medical Radioisotopes Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Medical Radioisotopes revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Medical Radioisotopes revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
NRG
NTP Radioisotopes
ANSTO
IRE
Nordion
Curium Pharma
Eckert & Ziegler Strahlen
Polatom
China National Nuclear Corporation
IDB Holland